Canakinumab efficacy in refractory adult-onset PFAPA syndrome

Giuseppe Lopalco; Donato Rigante; Antonio Vitale; Francesco Caso; Florenzo Iannone; Luca Cantarini

doi:10.1111/1756-185X.12722

Canakinumab efficacy in refractory adult-onset PFAPA syndrome

Giuseppe Lopalco
, Donato Rigante
, Antonio Vitale
, Francesco Caso
, Florenzo Iannone
, Luca Cantarini

Risultato della ricerca: Contributo in rivista › Articolo › peer review

13 Citazioni (Scopus)

Abstract

Efficacy of a long-acting anti-interleukin 1 agent is reported in an adult with a typical pediatric disease, PFAPA syndrome.

Lingua originale	Inglese
pagine (da-a)	1050-1051
Rivista	International Journal of Rheumatic Diseases
Volume	20
DOI	https://doi.org/10.1111/1756-185X.12722
Stato di pubblicazione	Pubblicato - 2017

Keywords

Canakinumab

Accesso al documento

10.1111/1756-185X.12722

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{1127d99cc84d4aee94b9c681824ea67e,

title = "Canakinumab efficacy in refractory adult-onset PFAPA syndrome",

abstract = "Efficacy of a long-acting anti-interleukin 1 agent is reported in an adult with a typical pediatric disease, PFAPA syndrome.",

keywords = "Canakinumab, Canakinumab",

author = "Giuseppe Lopalco and Donato Rigante and Antonio Vitale and Francesco Caso and Florenzo Iannone and Luca Cantarini",

year = "2017",

doi = "10.1111/1756-185X.12722",

language = "English",

volume = "20",

pages = "1050--1051",

journal = "International Journal of Rheumatic Diseases",

issn = "1756-1841",

publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Canakinumab efficacy in refractory adult-onset PFAPA syndrome

AU - Lopalco, Giuseppe

AU - Rigante, Donato

AU - Vitale, Antonio

AU - Caso, Francesco

AU - Iannone, Florenzo

AU - Cantarini, Luca

PY - 2017

Y1 - 2017

N2 - Efficacy of a long-acting anti-interleukin 1 agent is reported in an adult with a typical pediatric disease, PFAPA syndrome.

AB - Efficacy of a long-acting anti-interleukin 1 agent is reported in an adult with a typical pediatric disease, PFAPA syndrome.

KW - Canakinumab

UR - http://hdl.handle.net/10807/68747

U2 - 10.1111/1756-185X.12722

DO - 10.1111/1756-185X.12722

M3 - Article

SN - 1756-1841

VL - 20

SP - 1050

EP - 1051

JO - International Journal of Rheumatic Diseases

JF - International Journal of Rheumatic Diseases

ER -

Canakinumab efficacy in refractory adult-onset PFAPA syndrome

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo